Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J DellaValla
Untreated Essential Thrombocythemia Evolving to Biphenotypic Leukemia, Philadelphia Chromosome Positive With Monosomy 7: Response to Imatinib and Reduced-Intensity Allogeneic Stem Cell Transplant
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Multiple Myeloma With Concomitant JAK2-positive Essential Thrombocythemia Post-Successful Autologous Peripheral Blood Hematopoietic Stem Cell Transplant
Bone Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Preliminary Results of the Safety of Immunotherapy With Gemtuzumab Ozogamicin Following Reduced Intensity Allogeneic Stem Cell Transplant in Children With CD33+ Acute Myeloid Leukemia
Clinical Cancer Research
Cancer Research
Oncology
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
Donor-Derived Philadelphia Chromosome Positive B-Cell Lymphoblastic Leukemia Presenting With Renal Allograft Involvement in the First Year Post-Transplant
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia
Cancer Control
Medicine
Oncology
Hematology
Complete Remission From Chronic Myelogenous Leukemia-Blastic Crisis Caused by Reduced Intensity Stem Cell Transplantation Following Partial Remission Due to Imatinib
Internal Medicine
Internal Medicine
Medicine
BCR-ABL1 Mutations in Patients With Imatinib-Resistant Philadelphia Chromosome-Positive Leukemia by Use of the PCR-Invader Assay
Leukemia Research
Cancer Research
Oncology
Hematology